|
Volumn 364, Issue 9432, 2004, Pages 411-412
|
Over-the-counter statins [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
SIMVASTATIN;
NON PRESCRIPTION DRUG;
COMMUNITY;
DRUG COST;
GENERAL PRACTITIONER;
GOVERNMENT;
HEALTH SERVICE;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
ISCHEMIC HEART DISEASE;
LETTER;
MEDICAL DECISION MAKING;
MEDICAL EDUCATION;
NONHUMAN;
PHARMACIST;
PHYSICIAN;
PRESCRIPTION;
PRIORITY JOURNAL;
REDUCTION;
UNITED KINGDOM;
UNITED STATES;
CARDIOVASCULAR DISEASE;
DEVELOPING COUNTRY;
DRUG UTILIZATION;
ECONOMICS;
FORECASTING;
NOTE;
SOCIOECONOMICS;
STATISTICS;
CARDIOVASCULAR DISEASES;
DEVELOPING COUNTRIES;
DRUG COSTS;
DRUG UTILIZATION;
DRUGS, NON-PRESCRIPTION;
FORECASTING;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
SOCIOECONOMIC FACTORS;
|
EID: 4344647552
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(04)16750-0 Document Type: Letter |
Times cited : (2)
|
References (5)
|